Hyperion DeFi, Inc. (HYPD) is a U.S.-listed digital asset treasury and DeFi company building on the Hyperliquid blockchain, formerly known as Eyenovia, Inc. Two current, attributable analyst price targets were reviewed. Cantor Fitzgerald maintains an Overweight rating with a $11.20 target (raised from $7.10 on September 10, 2026), while Chardan Capital maintains a Buy rating with an $8.45 target (raised from $7.30 on September 8, 2026). The arithmetic mean of these two targets is $9.83, which rounds to the $9.80 central target used here. The low-to-high range is $8.45 to $11.20.
Because only two analysts cover the name, this is a thin sample rather than a robust consensus, and the roughly 33% spread between the two targets highlights how differently analysts can value a company whose fortunes hinge on a single crypto token. Both analysts' rationale centers on growing adjusted gross profit from ecosystem rewards, DeFi monetization, and yield enhancement in the second half of 2026, following the company's raised guidance and a $20 million share buyback. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
HYPD traded near $2.72 in mid-November 2026, with a market capitalization around $41 million, placing it firmly in micro-cap territory. Moving from $2.72 to $9.80 would require an upside of roughly 260%, a very large move by any measure. The path would likely depend on a meaningful re-rating driven by appreciation in the HYPE token, the company's primary treasury asset, combined with accelerating adjusted gross profit and broader crypto-sector momentum. The stock is highly volatile, with a beta above 2.7, meaning it tends to amplify market swings in either direction.
HYPD has a 52-week range spanning roughly $2.34 on the low end to about $5.63 on the high end, meaning the stock is trading in the lower portion of that range near $2.72. The $3.00 level represents a near-term psychological threshold, while the $5.50–$5.63 area marks the prior 52-week high and a longer-term resistance zone. The central $9.80 target sits well above any recent traded price, implying the market would need to break decisively above prior highs and establish a new, higher trading range for the target to become relevant.
Analyst price targets typically reflect a research horizon of about 12 months, though neither firm's published note specifies an exact date, and the wide $8.45–$11.20 range signals uncertainty about the pace of any move. Investors should watch HYPE token price action, quarterly adjusted gross profit against the $7 million–$8 million guidance, progress on capital redeployment into higher-yield strategies, any updates to the buyback program, and the next earnings report, as well as broader cryptocurrency market sentiment and interest-rate conditions that influence risk appetite. From what I see, this is important because the outcome hinges on several moving parts that could shift quickly.
In my own analysis, I often rely on Tickeron's AI Daily Buy/Sell Signals to monitor volatile names like this one. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. For a crypto-linked micro-cap, it can highlight momentum changes faster than manual review alone, helping spot potential turning points and maintain consistency when evaluating positions.
The central $9.80 target represents the average of just two current analyst price targets, a thin base that requires roughly 260% upside from the recent $2.72 price. The bull case rests on HYPE token appreciation, expanding staking and DeFi revenue, raised guidance, and a buyback, while the bear case centers on single-asset concentration, micro-cap volatility, and execution risk during a capital-redeployment transition. With only two analysts covering the stock and a wide $8.45–$11.20 target range, investors should treat the figure as a directional, high-risk scenario rather than a near-term expectation. What happens next to HYPE, to adjusted gross profit, and to crypto market sentiment will determine whether the path toward $9.80 becomes more or less plausible. No outcome is guaranteed, and the target should not be read as a forecast or a recommendation.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
HYPD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 31 of 34 cases where HYPD's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HYPD's RSI Indicator exited the oversold zone, 28 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +5.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where HYPD advanced for three days, in 187 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HYPD as a result. In 72 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for HYPD turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 37 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
HYPD moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HYPD crossed bearishly below the 50-day moving average on October 19, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
The 50-day moving average for HYPD moved below the 200-day moving average on November 10, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HYPD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for HYPD entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 33 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.380) is normal, around the industry mean (3.498). P/E Ratio (-0.664) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (25.707) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. HYPD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HYPD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which delivers sight saving therapies
Industry Biotechnology